We invest across Europe
in early-stage biopharma companies developping new therapeutics
€52 million
biotech-focused fund backed by the
European Investment Fund and other
public and private investors.
Enhancing
transformative treatments
Biovance Capital works closely with entrepeneurs to build leading companies with transformative treatments for patients in need. We invest in seed and Series A rounds and typically bring additional investors to add value and mitigate risk.
We grow
stronger,
together
We have developed a wide network across Europe that includes research institutes, incubators and accelerators. Through this network, we have access to a rich pipeline of potential investments.
Our latest news
No Posts Found!
Get our news
directly in the email
Subscribe to our newsletter and you’ll get them directly to your e-mail.